Cynthia Pussinen — CEO
CEO and board director with extensive global experience across biotech and pharmaceutical organizations, spanning discovery through commercialization. Trusted to lead companies through moments that matter most: formation, scale-up, capital raises, strategic partnerships, operational transformation, and governance evolution. Brings strong scientific fluency paired with disciplined execution in highly regulated environments. Known for clear decision making under pressure, constructive engagement with shareholders, and a strong sense of accountability to long-term enterprise value. Significant experience in biotech, advanced therapies, precision medicine, med tech, devices and pharmaceuticals providing strategic, operational, and functional leadership, including 6 years as a CEO, 3 years as a CTO | COO and 15+ years as a C-level or EVP | VP professional. • Led the development, licensure, commercialization and delivery of more than 15 new medical therapies to patients globally, delivering single peak year sales >$5B. • Drove a holistic turnaround of company | subsidiary operations, catapulting performance from last to first across all company subsidiaries, within ~18 months of assuming CEO | President role. • Raised non-dilutive capital through the out-license of a key asset and sale of capital assets >$300M; aggregate deal value >$1.5B • Contributed to raising and | or hard circling >$100M equity or venture debt investments for small biotech companies • Negotiated a ~$1.9B non-binding term sheet with a top 10 pharma partner • ‘Raised’ $750M-$1B from a top 10 pharma board for a significant infrastructure investment Particularly well-suited for CEO and board roles in life sciences companies facing strategic, leadership, or capital inflection points. Recognized for independent judgment, credibility with investors, and the ability to align science, strategy, and execution into durable outcomes.
Stackforce AI infers this person is a seasoned leader in the biotech and pharmaceutical industries.
Location: New York City, New York, United States
Experience: 31 yrs 2 mos
Skills
- Executive Leadership
- Pharmaceutical Industry
Career Highlights
- Led commercialization of therapies generating over $5B in sales.
- Raised over $1.5B through strategic partnerships and capital raises.
- Recognized for aligning science and strategy for durable outcomes.
Work Experience
Xelcis Bio Inc.
Member Board of Directors (8 mos)
Biotech CEO Sisterhood
Member (1 yr 6 mos)
Sernova
Chief Executive Officer | Member Board of Directors (1 yr 1 mo)
Tome Biosciences
Scientific & Technical Advisory Board Member (1 yr 4 mos)
Owl Bio Advisors
CEO | Executive Advisor & Consultant | Private Equity Advisor | Board Advisor | Board Member (3 yrs 2 mos)
MasterControl
Board of Directors Advisor and Executive Consultant (11 mos)
Spark Therapeutics, Inc.
Chief Technical Officer | Spark Therapeutics Board Director (UK and Ireland) (1 yr 11 mos)
Honeywell
Global Vice President & General Manager, Life Sciences & Specialty Chemicals (1 yr)
Actinium Pharmaceuticals, Inc.
Executive Vice President, Technical Development & Operations (COO) (1 yr)
Pfizer
Head of R&D Strategy & Portfolio (2 yrs)
Ipsen
Vice President, Technical Operations and Development (0 mo)
President | Chief Executive Officer, Ipsen Biosciences and Ipsen Biomeasure (Ipsen subsidiaries) (6 yrs)
Senior Director, Lifecycle Leader (1 yr)
Pfizer
Multiple Roles in R&D | Supply Chain | CDMO | Program Management (16 yrs)
Education
Master of Science - MS at Rensselaer Polytechnic Institute
Bachelor of Science (B.S.) Chemistry at University of Connecticut
Divinity and Theological Studies at Harvard Online